PolyOne Acquires Kraton TPE Assets

US specialty polymers company PolyOne has bought certain thermoplastic elastomer (TPE) technologies and assets from Kraton Performance Polymers for $72 million.

The two companies have also signed a supply agreement for which Kraton will provide PolyOne certain raw materials used in production for the acquired business.

The technologies serve new and fast growing applications in adhesive and removable protective films, adding to those already serviced by PolyOne which include packaging, medical devices and personal care products.

Kevin Fogarty, president and CEO of Kraton, said the deal allows PolyOne and Kraton to focus on their core competencies and help customers with new and unique solutions that differentiate them in the marketplace.

Separately, PolyOne has announced plans to close its engineered thermoplastics facility in Wichita, Kansas, USA. This latest closure is part of PolyOne’s effort to adjust its manufacturing footprint, according to CEO Robert Patterson.

No further details were provided on when the plant would close or how many jobs would be affected. However, Patterson said PolyOne would begin to see cost benefits from the closure in the second half of this year.

The Wichita facility was formerly owned by Spartech, which PolyOne acquired in 2013. PolyOne has shut a number of Spartech plants since the acquisition.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.